Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8453833 | Lung Cancer | 2018 | 16 Pages |
Abstract
To our knowledge, this is the largest dataset of patients treated with SRS alone for SCLC. The observation of favorable OS with SRS alone in this contemporary dataset suggests that SRS alone may be appropriate for some patients with SCLC. Prospective investigations of SRS in SCLC are warranted.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Tyler P. Robin, Bernard L. Jones, Arya Amini, Matthew Koshy, Laurie E. Gaspar, Arthur K. Liu, Sameer K. Nath, Brian D. Kavanagh, D. Ross Camidge, Chad G. Rusthoven,